These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15956117)

  • 1. Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo.
    Fecteau MH; Honoré JC; Plante M; Labonté J; Rae GA; D'Orléans-Juste P
    Hypertension; 2005 Jul; 46(1):87-92. PubMed ID: 15956117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs.
    Honoré JC; Plante M; Bkaily G; Rae GA; D'Orléans-Juste P
    Br J Pharmacol; 2002 Jul; 136(6):819-28. PubMed ID: 12110606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
    Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
    Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
    Held HD; Raschak M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta.
    Tirapelli CR; Fecteau MH; Honore JC; Legros E; Gobeil F; D'Orleans-Juste P
    Br J Pharmacol; 2006 Jun; 148(4):527-35. PubMed ID: 16633356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
    Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
    Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Trapani AJ; Beil ME; Bruseo CW; Savage P; Firooznia F; Jeng AY
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.
    Trapani AJ; De Lombaert S; Kuzmich S; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S69-71. PubMed ID: 8587471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
    McMahon EG; Palomo MA; Moore WM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit.
    Gratton JP; Rae GA; Bkaily G; D'Orléans-Juste P
    Hypertension; 2000 Mar; 35(3):726-31. PubMed ID: 10720586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors.
    Vatter H; Schilling L; Schmiedek P; Ehrenreich H
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S64-7. PubMed ID: 9595402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery.
    Tirapelli CR; Casolari DA; Yogi A; Tostes RC; Legros E; Lanchote VL; Uyemura SA; de Oliveira AM
    Alcohol; 2007 Mar; 41(2):77-85. PubMed ID: 17466482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
    Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
    Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; De Lombaert S; Jeng AY
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S40-3. PubMed ID: 11078331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Big ET-1 processing into vasoactive peptides in arteries and veins.
    Watts SW; Thakali K; Smark C; Rondelli C; Fink GD
    Vascul Pharmacol; 2007; 47(5-6):302-12. PubMed ID: 17904426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
    Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
    Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
    Yap EY; Battistini B; McKay KO
    Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
    Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
    Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.